Status:
TERMINATED
A Reminder App to Reduce Radiation Dermatitis Rates in Patients with Head-and-Neck Cancer
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Radiation Dermatitis
Radiation-induced Oral Mucositis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this randomized trial is to investigate whether the addition of a reminder app to standard care leads to a reduction of dermatitis and oral mucositis during radio(chemo)therapy for locally...
Detailed Description
The goal of this trial is to investigate whether the addition of a reminder app to standard care leads to a reduction of dermatitis and oral mucositis during radio(chemo)therapy for locally advanced s...
Eligibility Criteria
Inclusion
- Histologically proven squamous cell carcinoma of the head-and-neck (SCCHN)
- Indication for definitive or adjuvant radio(chemo)therapy
- Possession of and ability to use a smart phone
- Age ≥18 years
- Written informed consent
- Capacity of the patient to contract
Exclusion
- Nasopharynx cancer
- Pregnancy, Lactation
- Treatment with epidermal growth factor receptor (EGFR)-antibodies (either given or planned)
- Expected non-compliance
Key Trial Info
Start Date :
October 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04110977
Start Date
October 10 2020
End Date
December 5 2022
Last Update
January 15 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Practice for Radiotherapy and Radiation Oncology
Hanover, Lower Saxony, Germany, 30449
2
Dept. of Radiation Oncology, University of Lübeck
Lübeck, Schleswig-Holstein, Germany, 23562
3
Dept. of Radiation Oncology, Hospital Universitario y Politecnico La Fe,
Valencia, Valencia, Spain
4
Department of Radiation Oncology, Cruces University Hospital/ Biocruces Health Research Institute
Barakaldo, Vizcaya, Spain